NL6901341A - - Google Patents

Info

Publication number
NL6901341A
NL6901341A NL6901341A NL6901341A NL6901341A NL 6901341 A NL6901341 A NL 6901341A NL 6901341 A NL6901341 A NL 6901341A NL 6901341 A NL6901341 A NL 6901341A NL 6901341 A NL6901341 A NL 6901341A
Authority
NL
Netherlands
Application number
NL6901341A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6901341A publication Critical patent/NL6901341A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL6901341A 1968-01-29 1969-01-28 NL6901341A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB456968A GB1260464A (en) 1968-01-29 1968-01-29 11beta-HALO-STEROIDS

Publications (1)

Publication Number Publication Date
NL6901341A true NL6901341A (cg-RX-API-DMAC7.html) 1969-07-31

Family

ID=9779625

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6901341A NL6901341A (cg-RX-API-DMAC7.html) 1968-01-29 1969-01-28

Country Status (6)

Country Link
CH (1) CH547789A (cg-RX-API-DMAC7.html)
DE (1) DE1904324A1 (cg-RX-API-DMAC7.html)
DK (1) DK130646B (cg-RX-API-DMAC7.html)
FR (1) FR2000923A1 (cg-RX-API-DMAC7.html)
GB (1) GB1260464A (cg-RX-API-DMAC7.html)
NL (1) NL6901341A (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052929A1 (cg-RX-API-DMAC7.html) * 1969-06-04 1971-04-16 Bristol Myers Co

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052929A1 (cg-RX-API-DMAC7.html) * 1969-06-04 1971-04-16 Bristol Myers Co

Also Published As

Publication number Publication date
DK130646C (cg-RX-API-DMAC7.html) 1975-08-25
DK130646B (da) 1975-03-17
FR2000923A1 (cg-RX-API-DMAC7.html) 1969-09-19
CH547789A (de) 1974-04-11
GB1260464A (en) 1972-01-19
DE1904324A1 (de) 1969-09-11

Similar Documents

Publication Publication Date Title
AU428130B2 (cg-RX-API-DMAC7.html)
AU2374870A (cg-RX-API-DMAC7.html)
AU5184069A (cg-RX-API-DMAC7.html)
AU6168869A (cg-RX-API-DMAC7.html)
AU6171569A (cg-RX-API-DMAC7.html)
AU429879B2 (cg-RX-API-DMAC7.html)
AU416157B2 (cg-RX-API-DMAC7.html)
AU2581067A (cg-RX-API-DMAC7.html)
DK130646C (cg-RX-API-DMAC7.html)
AU4811568A (cg-RX-API-DMAC7.html)
AU421558B1 (cg-RX-API-DMAC7.html)
AU4744468A (cg-RX-API-DMAC7.html)
AU3789668A (cg-RX-API-DMAC7.html)
AU3224368A (cg-RX-API-DMAC7.html)
AU2580267A (cg-RX-API-DMAC7.html)
AU479393A (cg-RX-API-DMAC7.html)
BE642636A (cg-RX-API-DMAC7.html)
AU4558658A (cg-RX-API-DMAC7.html)
AU463027A (cg-RX-API-DMAC7.html)
AU4464266A (cg-RX-API-DMAC7.html)
BE727058A (cg-RX-API-DMAC7.html)
AU479894A (cg-RX-API-DMAC7.html)
AU4270368A (cg-RX-API-DMAC7.html)
AU4224469A (cg-RX-API-DMAC7.html)
AU3083868A (cg-RX-API-DMAC7.html)